BCHE and Mental deterioration: Regarding anti‐dementia medications, 75% of patients in the rapid cognitive decline group were taking cholinesterase inhibitors, while in the slow cognitive decline group, 100% were on cholinesterase inhibitors, and 25% were taking N‐methyl‐D‐aspartate (NMDA) antagonists (full medication list is provided as Table S1).